Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 901686, 15 pages
http://dx.doi.org/10.1155/2014/901686
Review Article

Do Nutritional Supplements Have a Role in Age Macular Degeneration Prevention?

1University of Valencia, Spain
2The Ophthalmic Research Unit “Santiago Grisolía”, Valencia, Spain
3University of Santiago de Compostela, Spain
4The Institute Gomez-Ulla, Santiago de Compostela, Spain
5Foundation RetinaPlus, Spain
6University of Barcelona, Spain
7Retina Section, Department of Ophthalmology, Bellvitge University Hospital, Barcelona, Spain
8Vitreous and Retina Department, UPV/EHU and Instituto Clínico Quirúrgico de Oftalmología (ICQO), University of the Basque Country, Bilbao, Spain
9Clinic Institute of Ophthalmology, Clinic Hospital of Barcelona, University of Barcelona, Barcelona, Spain
10Macula Section, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Valencia, Spain
11University of Murcia, General University Hospital Reina Sofia, Murcia, Spain
12Ophthalmic Reseach Unit “Santiago Grisolia”, Valencia, Spain
13The University of Valladolid, Diabetes and Telemedicine Unit at the IOBA, Spain
14The Retina Unit of the Clinic University Hospital of Valladolid, Spain
15The University of Valladolid, Spain
16The Vitreo-Retina Unit of the Clinic University Hospital of Valladolid, Spain
17Research Institute of the Hospital of Vall Hebron, Barcelona, Spain
18Retina Section of the Hospital of Vall Hebron, The Universidad Autònoma de Barcelona, Barcelona, Spain
19Faculty of Medicine, University of Valencia, Valencia, Spain
20University and Polytechnic Hospital La Fe, Valencia, Spain
21University of Navarra Clinic, Pamplona, Spain

Received 22 July 2013; Accepted 12 October 2013; Published 23 January 2014

Academic Editor: Jürgen Groll

Copyright © 2014 Maria D. Pinazo-Durán et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Soubrane, A. Cruess, A. Lotery et al., “Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study,” Archives of Ophthalmology, vol. 125, no. 9, pp. 1249–1254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Miller, “Age-related macular degeneration revisited—piecing the puzzle: the LXIX Edward Jackson memorial lecture,” The American Journal of Ophthalmology, vol. 155, pp. 1–35, 2013. View at Google Scholar
  3. T. Lin, G. B. Walker, K. Kurji et al., “Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye,” Cytokine, vol. 62, pp. 369–381, 2013. View at Google Scholar
  4. A. Swaroop, E. Y. Chew, C. B. Rickman, and G. R. Abecasis, “Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration,” Annual Review of Genomics and Human Genetics, vol. 10, pp. 19–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Aslam, C. Delcourt, R. Silva et al., “Micronutrients in age-related macular degeneration,” Ophthalmologica, vol. 229, pp. 75–79, 2012. View at Google Scholar
  6. Age-Related Eye Disease Study Research Group, “A randomized, placebo-controled clinical trial of high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and visual loss: AREDS report 8,” Archives of Ophthalmology, vol. 119, pp. 1417–1436, 2001. View at Google Scholar
  7. Age-Related Eye Disease Study 2 Research Group, “Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial,” The Journal of the American Medical Association, vol. 309, pp. 2005–2015, 2013. View at Google Scholar
  8. I. Fridovich, “The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity: superoxide dismutases provide an important defense,” Science, vol. 201, no. 4359, pp. 875–880, 1978. View at Google Scholar · View at Scopus
  9. B. Halliwell, “Free radicals and antioxidants: updating a personal view,” Nutrition Reviews, vol. 70, no. 5, pp. 257–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. W. A. Pryor, “Free radicals and lipid peroxidation: what they are and how theygot that way,” in Natural Antioxidants in Human Health and Disease, B. Frei, Ed., pp. 1–24, Academic Press, San Diego, Calif, USA, 1994. View at Google Scholar
  11. N. Acar, S. Gregoire, A. Andre et al., “Plasmalogens in the retina: in situ hybridization of dihydroxyacetone phosphate acyltransferase (DHAP-AT)—the first enzyme involved in their biosynthesis—and comparative study of retinal and retinal pigment epithelial lipid composition,” Experimental Eye Research, vol. 84, no. 1, pp. 143–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Acar, O. Berdeaux, S. Grégoire et al., “Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids?” PLoS ONE, vol. 7, no. 4, Article ID e35102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. T. Holman, L. Smythe, and S. Johnson, “Effect of sex and age on fatty acid composition of human serum lipids,” The American Journal of Clinical Nutrition, vol. 32, no. 12, pp. 2390–2399, 1979. View at Google Scholar · View at Scopus
  14. J. C. Khan, H. Shahid, D. A. Thurlby et al., “Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight,” The British Journal of Ophthalmology, vol. 90, no. 1, pp. 29–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Smith, J. Assink, R. Klein et al., “Risk factors for age-related macular degeneration: pooled findings from three continents,” Ophthalmology, vol. 108, no. 4, pp. 697–704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Klein, B. E. Klein, S. C. Jensen, J. A. Mares-Perlman, K. J. Cruickshanks, and M. Palta, “Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III,” Ophthalmology, vol. 106, no. 6, pp. 1056–1065, 1999. View at Google Scholar · View at Scopus
  17. R. Varma, S. Fraser-Bell, S. Tan, R. Klein, S. P. Azen, and Los Angeles Latino Eye Study Group, “Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study,” Ophthalmology, vol. 111, no. 7, pp. 1288–1297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Zarbin, “Current concepts in the pathogenesis of age-related macular degeneration,” Archives of Ophthalmology, vol. 122, no. 4, pp. 598–614, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. N. I. Krinsky, J. T. Landrum, and R. A. Bone, “Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye,” Annual Review of Nutrition, vol. 23, pp. 171–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Pauleikhoff, F. J. van Kuijk, and A. C. Bird, “Macular pigment and age-related macular degeneration,” Ophthalmologe, vol. 98, no. 6, pp. 511–519, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Wu, S. Seregard, and P. V. Algvere, “Photochemical damage of the retina,” Survey of Ophthalmology, vol. 51, no. 5, pp. 461–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. V. Algvere, J. Marshall, and S. Seregard, “Age-related maculopathy and the impact of blue light hazard,” Acta Ophthalmologica Scandinavica, vol. 84, no. 1, pp. 4–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. H. Margrain, M. Boulton, J. Marshall, and D. H. Sliney, “Do blue light filters confer protection against age-related macular degeneration?” Progress in Retinal and Eye Research, vol. 23, no. 5, pp. 523–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Klein, B. E. Klein, S. C. Jensen, and K. J. Cruickshanks, “Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 119, pp. 246–250, 2001. View at Google Scholar
  25. L. Biasutto, A. Chiechi, R. Couch, L. A. Liotta, and V. Espina, “The RPE exosomes contain signaling phosphoproteins affected by oxidative stress,” Experimental Cell Research, vol. 119, pp. 2113–2123, 2013. View at Google Scholar
  26. S. Beatty, H. Koh, M. Phil, D. Henson, and M. Boulton, “The role of oxidative stress in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 45, no. 2, pp. 115–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. P. C. Calder, “Polyunsaturated fatty acids, inflammation, and immunity,” Lipids, vol. 36, no. 9, pp. 1007–1024, 2001. View at Google Scholar · View at Scopus
  28. P. K. Mukherjee, V. L. Marcheselli, J. C. de Rivero Vaccari, W. C. Gordon, F. E. Jackson, and N. G. Bazan, “Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 32, pp. 13158–13163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. D. Pinazo-Durán and L. Boscá-Gomar, “Anti-inflammatory properties of polyunsaturated fatty acid omega 3,” Indications in Ophthalmology, vol. 87, pp. 203–205, 2012. View at Google Scholar
  30. J. Blasiak, S. Glowacki, A. Kauppinen, and K. Kaarniranta, “Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration,” International Journal of Molecular, vol. 14, no. 2, pp. 2996–3010, 2013. View at Google Scholar
  31. E. Synowiec, T. Sliwinski, K. Danisz et al., “Association between polymorphism of the NQO1, NOS3 and NFE2L2 genes and AMD,” Frontiers in Bioscience, vol. 18, pp. 80–90, 2013. View at Google Scholar
  32. M. C. Kenney, D. Hertzog, G. Chak et al., “Mitochondrial DNA haplogroups confer differences in risk for age-related macular degeneration: a case control study,” BMC Medical Genetics, vol. 14, article 4, 2013. View at Google Scholar
  33. T. U. Krohne, N. K. Stratmann, J. Kopitz, and F. G. Holz, “Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells,” Experimental Eye Research, vol. 90, no. 3, pp. 465–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. D. Pinazo-Durán, V. Zanón-Moreno, J. J. García-Medina, and R. Gallego-Pinazo, “Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma,” Current Opinion in Pharmacology, vol. 13, pp. 98–107, 2013. View at Google Scholar
  35. R. Dănulescu and D. Costin, “Use of blood markers in early diagnosis of oxidative stress in age related macular degeneration,” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 116, no. 4, pp. 1136–1142, 2012. View at Google Scholar
  36. J. Yao, X. Liu, Q. Yang et al., “Proteomic analysis of the aqueous humor in patients with wet age-related macular degeneration,” Proteomics Clinical Applications, vol. 7, no. 550, pp. 7–860, 2013. View at Google Scholar
  37. R. T. Libby and D. B. Gould, “Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration,” Advances in Experimental Medicine and Biology, vol. 664, pp. 403–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Rodríguez Diez, S. Sánchez Campos, N. M. Giusto, and G. A. Salvador, “Specific roles for Group V secretory PLA2 in retinal iron-induced oxidative stress. Implications for age-related macular degeneration,” Experimental Eye Research, vol. 113, pp. 172–181, 2013. View at Google Scholar
  39. V. Nikoletopoulou, M. Markaki, K. Palikaras, and N. Tavernarakis, “Crosstalk between apoptosis, necrosis and autophagy,” Biochimica et Biophysica Acta, vol. 1833, no. 12, pp. 3448–3459, 2013. View at Publisher · View at Google Scholar
  40. D. D'Amours, F. R. Sallmann, V. M. Dixit, and G. G. Poirier, “Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis,” Journal of Cell Science, vol. 114, no. 20, pp. 3771–3778, 2001. View at Google Scholar · View at Scopus
  41. J. H. Distler, T. Strapatsas, D. Huscher et al., “Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease,” Annals of the Rheumatic Diseases, vol. 70, no. 7, pp. 1197–1202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. P. K. Kaiser, “Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline,” Ophthalmology, vol. 120, no. 5, Supplement, pp. S11–S15, 2013. View at Google Scholar
  43. S. Rezzola, M. Belleri, D. Ribatti, C. Costagliola, M. Presta, and F. Semeraro, “A novel ex vivo murine retina angiogenesis (EMRA) assay,” Experimental Eye Research, vol. 112, pp. 51–56, 2013. View at Google Scholar
  44. R. Seki, S. Yamagishi, T. Matsui et al., “Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties,” Biochemical and Biophysical Research Communications, vol. 431, pp. 693–697, 2013. View at Google Scholar
  45. A. Stahl, M. T. Stumpp, A. Schlegel et al., “Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications,” Angiogenesis, vol. 16, pp. 101–111, 2013. View at Google Scholar
  46. S. Nakao, M. Arima, K. Ishikawa et al., “Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis,” Investigative Ophthalmology & Visual Science, vol. 53, pp. 4323–4328, 2012. View at Google Scholar
  47. I. A. Bhutto, D. S. McLeod, T. Hasegawa et al., “Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration,” Experimental Eye Research, vol. 82, no. 1, pp. 99–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. Stefater III, I. Lewkowich, S. Rao et al., “Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells,” Nature, vol. 474, no. 7352, pp. 511–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Klettner, A. Kauppinen, J. Blasiak, J. Roider, A. Salminen, and K. Kaarniranta, “Cellular and molecular mechanisms of age-related macular degeneration: from impaired autophagy to neovascularization,” The International Journal of Biochemistry & Cell Biology, vol. 45, pp. 1457–1467, 2013. View at Google Scholar
  50. W. M. Haddad, G. Coscas, and G. Soubrane, “Age-related macular degeneration and apoptosis,” Journal Francais d'Ophtalmologie, vol. 26, no. 3, pp. 307–311, 2003. View at Google Scholar · View at Scopus
  51. J. L. Dunaief, T. Dentchev, G. S. Ying, and A. H. Milam, “The role of apoptosis in age-related macular degeneration,” Archives of Ophthalmology, vol. 120, no. 11, pp. 1435–1442, 2002. View at Google Scholar · View at Scopus
  52. N. Liadis, K. Murakami, M. Eweida et al., “Caspase-3-dependent β-cell apoptosis in the initiation of autoimmune diabetes mellitus,” Molecular and Cellular Biology, vol. 25, no. 9, pp. 3620–3629, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Matés, “Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology,” Toxicology, vol. 153, no. 1–3, pp. 83–104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. L. M. Sadaba, P. Fernandez-Robredo, J. A. Rodríguez, and A. García-Layana, “Antioxidant effects of vitamins C and E, multivitamin-mineral complex and flavonoids in a model of retinal oxidative stress: the ApoE-deficient mouse,” Experimental Eye Research, vol. 86, no. 3, pp. 470–479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Jialal, S. Devaraj, and N. Kaul, “The effect of α-Tocopherol on monocyte proatherogenic activity,” Journal of Nutrition, vol. 131, pp. 389S–394S, 2001. View at Google Scholar · View at Scopus
  56. D. Zhang, M. Al-Hendy, G. Richard-Davis, V. Montgomery-Rice, V. Rajaratnam, and A. Al-Hendy, “Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells,” Fertility and Sterility, vol. 94, no. 5, pp. 1887–1893, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. Ungvari, Z. Orosz, A. Rivera, N. Labinskyy, Z. Xiangmin, and A. Csiszae, “Resveratrol increases vascular oxidative stress resistance,” The FASEB Journal, vol. 21, p. 576.2, 2007. View at Google Scholar
  58. R. Medzhitov and C. Janeway Jr., “Innate immunity,” The New England Journal of Medicine, vol. 343, no. 5, pp. 338–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Cao, G. B. Walker, X. Wang, J. Z. Cui, and J. A. Matsubara, “Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence,” Molecular Vision, vol. 19, pp. 718–728, 2013. View at Google Scholar
  60. F. Parmeggiani, D. Gemmati, C. Costagliola, A. Sebastiani, and C. Incorvaia, “Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration,” Pharmacogenomics, vol. 10, no. 1, pp. 81–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Cruz-Guilloty, A. M. Saeed, J. J. Echegaray et al., “Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration,” International Journal of Inflammation, vol. 2013, Article ID 503725, 12 pages, 2013. View at Publisher · View at Google Scholar
  62. R. P. Casaroli-Marano, J. Peinado-Onsurbe, M. Reina, B. Staels, J. Auwerx, and S. Vilaró, “Lipoprotein lipase in highly vascularized structures of the eye,” Journal of Lipid Research, vol. 37, no. 5, pp. 1037–1044, 1996. View at Google Scholar · View at Scopus
  63. D. H. Anderson, K. C. Talaga, A. J. Rivest, E. Barron, G. S. Hageman, and L. V. Johnson, “Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration,” Experimental Eye Research, vol. 78, no. 2, pp. 243–256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. G. S. Hageman, P. J. Luthert, N. H. V. Chong, L. V. Johnson, D. H. Anderson, and R. F. Mullins, “An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration,” Progress in Retinal and Eye Research, vol. 20, no. 6, pp. 705–732, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. J. J. Alexander, L. Bao, A. Jacob, D. M. Kraus, V. M. Holers, and R. J. Quigg, “Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis,” Biochimica et Biophysica Acta, vol. 1639, no. 3, pp. 169–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. D. A. Newsome, M. Swartz, N. C. Leone, R. C. Elston, and E. Miller, “Oral zinc in macular degeneration,” Archives of Ophthalmology, vol. 106, no. 2, pp. 192–198, 1988. View at Google Scholar · View at Scopus
  67. S. Richer, W. Stiles, L. Statkute et al., “Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial),” Optometry, vol. 75, no. 4, pp. 216–230, 2004. View at Google Scholar · View at Scopus
  68. M. Stur, M. Tittl, A. Reitner, and V. Meisinger, “Oral zinc and the second eye in age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 37, no. 7, pp. 1225–1235, 1996. View at Google Scholar · View at Scopus
  69. D. A. Newsome, “A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration,” Current Eye Research, vol. 33, no. 7, pp. 591–598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Richer, “Multicenter ophthalmic and nutritional age-related macular degeneration study—part 2: antioxidant intervention and conclusions,” Journal of the American Optometric Association, vol. 67, no. 1, pp. 30–49, 1996. View at Google Scholar · View at Scopus
  71. J. Feher, B. Kovacs, I. Kovacs, M. Schvoller, A. Papale, and C. B. Gabrieli, “Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10,” Ophthalmologica, vol. 219, no. 3, pp. 154–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. E. W. Chong, A. J. Kreis, T. Y. Wong, J. A. Simpson, and R. H. Guymer, “Dietary ω-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis,” Archives of Ophthalmology, vol. 126, no. 6, pp. 826–833, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. W. G. Christen, D. A. Schaumberg, R. J. Glynn, and J. E. Buring, “Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women,” Archives of Ophthalmology, vol. 129, no. 7, pp. 921–929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. R. van Leeuwen, S. Boekhoorn, J. R. Vingerling et al., “Dietary intake of antioxidants and risk of age-related macular degeneration,” The Journal of the American Medical Association, vol. 294, no. 24, pp. 3101–3107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Flood, W. Smith, J. J. Wang, F. Manzi, K. Webb, and P. Mitchell, “Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study,” Ophthalmology, vol. 109, no. 12, pp. 2272–2278, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. E. Chow, J. M. Seddon, B. Rosner, W. C. Willett, and S. E. Hankinson, “Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy,” Archives of Ophthalmology, vol. 122, no. 6, pp. 883–892, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. G. M. van den Langenberg, J. A. Mares-Perlman, R. Klein, B. E. K. Klein, W. E. Brady, and M. Palta, “Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the beaver dam eye study,” The American Journal of Epidemiology, vol. 148, no. 2, pp. 204–214, 1998. View at Google Scholar · View at Scopus
  78. M. S. Moeller, N. Parekh, L. L. Tinker et al., “Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative,” Archives of Ophthalmology, vol. 124, no. 8, pp. 1151–1162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Taylor, G. Tikellis, L. Robman et al., “Vitamin E supplementation and macular degeneration: randomised controlled trial,” British Medical Journal, vol. 325, no. 7354, pp. 11–14, 2002. View at Google Scholar · View at Scopus
  80. W. G. Hodge, H. M. Schachter, D. Barnes et al., “Efficacy of ω-3 fatty acids in preventing age-related macular degeneration: a systematic review,” Ophthalmology, vol. 113, no. 7, pp. 1165–1173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. E. W. Chong, T. Y. Wong, A. J. Kreis, J. A. Simpson, and R. H. Guymer, “Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis,” The British Medical Journal, vol. 335, no. 7623, pp. 755–759, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. E. H. Soused, C. Delcourt, G. Querques et al., “Nutritional AMD treatment 2 study group. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study,” Ophthalmology, vol. 120, no. 8, pp. 1619–1631, 2013. View at Google Scholar
  83. J. M. Teikari, L. Laatikainen, J. Virtamo et al., “Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy,” Acta Ophthalmologica Scandinavica, vol. 76, no. 2, pp. 224–229, 1998. View at Google Scholar · View at Scopus
  84. O. P. Heinonen, J. K. Huttunen, D. Albanes et al., “The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group,” Annals of Epidemiology, vol. 4, no. 1, pp. 1–10, 1994. View at Google Scholar · View at Scopus
  85. G. E. Goodman, G. S. Omenn, M. D. Thornquist, B. Lund, B. Metch, and I. Gylys-Colwell, “The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers,” Cancer Epidemiology Biomarkers and Prevention, vol. 2, no. 4, pp. 389–396, 1993. View at Google Scholar · View at Scopus
  86. G. S. Omenn, G. E. Goodman, M. D. Thornquist et al., “Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease,” The New England Journal of Medicine, vol. 334, no. 18, pp. 1150–1155, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. J. S. Tan, J. J. Wang, V. Flood, E. Rochtchina, W. Smith, and P. Mitchell, “Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study,” Ophthalmology, vol. 115, no. 2, pp. 334–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. J. H. Olson, J. C. Erie, and S. J. Bakri, “Nutritional supplementation and age-related macular degeneration,” Seminars in Ophthalmology, vol. 26, no. 3, pp. 131–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. Food and Nutrition Board, Institute of Medicine, “Copper,” in Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, pp. 224–257, National Academy Press, Washington, DC, USA, 2001. View at Google Scholar
  90. Z. B. Kang, Y. Ge, Z. Chen et al., “Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4050–4054, 2001. View at Google Scholar
  91. M. E. Pennesi, M. Neuringer, and R. J. Courtney, “Animal models of age related macular degeneration,” Molecular Aspects of Medicine, vol. 33, pp. 487–509, 2012. View at Google Scholar
  92. T. Koto, N. Nagai, H. Mochimaru et al., “Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice,” Investigative Ophthalmology & Visual Science, vol. 48, no. 9, pp. 4328–4334, 2007. View at Google Scholar
  93. J. Tuo, C. M. Bojanowski, M. Zhou et al., “Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 48, no. 8, pp. 3827–3836, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. C. C. Chan, R. J. Ross, D. Shen et al., “Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration,” Ophthalmic Research, vol. 40, no. 3-4, pp. 124–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Tuo, R. J. Ross, A. A. Herzlich et al., “A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration,” The American Journal of Pathology, vol. 175, no. 2, pp. 799–807, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. R. W. Bellhorn, C. D. King, G. D. Aguirre, H. Ripps, I. M. Siegel, and H. C. Tsai, “Pigmentary abnormalities of the macula in rhesus monkeys: clinical observations,” Investigative Ophthalmology and Visual Science, vol. 21, no. 6, pp. 771–781, 1981. View at Google Scholar · View at Scopus
  97. T. J. Stafford, S. H. Anness, and B. S. Fine, “Spontaneous degenerative maculopathy in the monkey,” Ophthalmology, vol. 91, no. 5, pp. 513–521, 1984. View at Google Scholar · View at Scopus
  98. M. G. Nicolas, K. Fujiki, K. Murayama et al., “Studies on the mechanism of early onset macular degeneration in cynomolgus (Macaca fascicularis) monkeys. I. Abnormal concentrations of two proteins in the retina,” Experimental Eye Research, vol. 62, no. 3, pp. 211–219, 1996. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Umeda, M. T. Suzuki, H. Okamoto et al., “Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis),” The FASEB Journal, vol. 19, no. 12, pp. 1683–1685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Neuringer, P. J. Francis, L. Renner, A. Weiss, and B. G. Jeffrey, “Atrophic macular degeneration in rhesus monkeys deficient in xanthophylls and n-3 fatty acids,” ARVO Abstract, Association for Research in Vision and Ophthalmology, 2010. View at Google Scholar
  101. P. Gouras, L. Ivert, M. Neuringer, and J. A. Mattison, “Topographic and age-related changes of the retinal epithelium and Bruch's membrane of rhesus monkeys,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 7, pp. 973–984, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. L. Renner, S. Hurst, T. McGill et al., “Progression of atrophic macular degeneration in rhesus monkeys deficient in lutein/zeaxanthin and omega-3 fatty acids,” ARVO Abstract, Association for Research in Vision and Ophthalmology, 2013. View at Google Scholar
  103. F. M. Barker II, D. M. Snodderly, E. J. Johnson et al., “Nutritional manipulation of primate retinas. V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage,” Investigative Ophthalmology & Visual Science, vol. 52, pp. 3934–3942, 2011. View at Google Scholar
  104. T. Tsuzuki, A. Shibata, Y. Kawakami, K. Nakagawa, and T. Miyazawa, “Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells,” Journal of Nutrition, vol. 137, no. 3, pp. 641–646, 2007. View at Google Scholar · View at Scopus
  105. N. Papadopoulos, J. Martin, Q. Ruan et al., “Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab,” Angiogenesis, vol. 15, pp. 171–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. D. Richard, K. Kefi, U. Barbe, P. Bausero, and F. Visioli, “Polyunsaturated fatty acids as antioxidants,” Journal of Regenerative Medicine and Tissue Engineering, vol. 2, pp. 383–393, 2008. View at Google Scholar
  107. E. Banumathi, R. Haribalaganesh, S. S. P. Babu, N. S. Kumar, and G. Sangiliyandi, “High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels,” Microvascular Research, vol. 77, no. 3, pp. 377–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Sheikpranbabu, R. Haribalaganesh, E. Banumathi, N. Sirishkumar, K. J. Lee, and S. Gurunathan, “Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells,” Life Sciences, vol. 85, pp. 719–731, 2009. View at Google Scholar
  109. I. Morita, Y. W. Zhang, and S. I. Murota, “Eicosapentaenoic acid protects endothelial cell function injured by hypoxia/reoxygenation,” Annals of the New York Academy of Sciences, vol. 947, pp. 394–397, 2001. View at Google Scholar · View at Scopus
  110. P. K. Mukherjee, V. L. Marcheselli, C. N. Serhan, and N. G. Bazan, “Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 22, pp. 8491–8496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. A. J. Chucair, N. P. Rotstein, J. P. Sangiovanni, A. During, E. Y. Chew, and L. E. Politi, “Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid,” Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 5168–5177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. R. Kannan, N. Zhang, P. G. Sreekumar et al., “Stimulation of apical and basolateral vascular endothelial growth factor-A and vascular endothelial growth factor-C secretion by oxidative stress in polarized retinal pigment epithelial cells,” Molecular Vision, vol. 12, pp. 1649–1659, 2006. View at Google Scholar · View at Scopus
  113. D. B. Kagan, H. Liu, and C. M. Hutnik, “Efficacy of various antioxidants in the protection of the retinal pigment epithelium from oxidative stress,” Clinical Ophthalmology, vol. 6, pp. 1471–1476, 2012. View at Publisher · View at Google Scholar
  114. J. Evans, “Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis,” Eye, vol. 22, no. 6, pp. 751–760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. A. Sujak, J. Gabrielska, W. Grudziński, R. Borc, P. Mazurek, and W. I. Gruszecki, “Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects,” Archives of Biochemistry and Biophysics, vol. 371, no. 2, pp. 301–307, 1999. View at Publisher · View at Google Scholar · View at Scopus